|
Reuters Health eLine
|
A daily look at the top consumer-oriented health-related news stories.
|
-
Higher heart risk seen in younger African Americans
NEW YORK (Reuters Health) - African Americans are known to have a higher rate of heart disease and stroke than whites, and a new study suggests that those excess risks emerge at a relatively young age.
-
Short sleep ups future obesity risk in young kids
NEW YORK (Reuters Health) - Young children who don't get enough sleep may be at greater risk of becoming overweight or obese later on, new research shows.
-
Mystery eye problem at dairy show caused by cow urine
SYDNEY (Reuters Life!) - The cause of a mystery eye ailment that struck about 50 visitors to a dairy pavilion at an agricultural show in Australia has been traced -- to cow urine.
-
Judge refuses to lift ban on government stem cell funds
WASHINGTON (Reuters) - A U.S. judge refused on Tuesday to lift a ban on federal funding of human embryonic stem cell research despite Obama administration warnings it would set back key research and cost more than a thousand jobs.
-
Statins linked to lower rheumatoid arthritis risk
LONDON (Reuters) - Israeli scientists have found a significant link between taking cholesterol-lowering statin drugs like Lipitor or Crestor and a reduced risk of developing rheumatoid arthritis.
-
Report says obesity surgery can save health costs
LONDON (Reuters) - Providing surgical treatment for people who are morbidly obese could save British taxpayer-funded health services and the wider economy hundreds of millions of pounds a year, leading surgeons said on Wednesday.
-
EU agency poses new questions on Avandia
LONDON (Reuters) - The European Medicines Agency said it was asking GlaxoSmithKline additional questions about its diabetes drug Avandia before giving a final verdict later this month on whether it should stay on the market.
-
US asks appeals court to stay stem cell funding ban
WASHINGTON (Reuters) - The Obama administration on Wednesday asked a U.S. appeals court for an emergency stay that would lift the ban on federal funding of research involving human embryonic stem cells.
-
New Alzheimer's approach may sidestep early snags
CHICAGO (Reuters) - A new Alzheimer's compound kept toxic clumps from forming in the brains of mice, without causing side effects seen in similar drugs, U.S. researchers said on Wednesday.
-
Drug co. paid writers to promote hormone therapy
CHICAGO (Reuters) - Drugmaker Wyeth used ghostwriters to play up the benefits and downplay the harm of hormone replacement therapy in articles published in medical journals, a U.S. researcher said on Tuesday.
|
